SELL Polycab India Limited — Manas Jaiswal
byManas JaiswalHorizon: NA (inferred Intraday)2 Sept 2026, 9:04 am ISTvia CNBC Awaaz.
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this SELL call — facts from public sources, machine-classified. Not investment advice.
Polycab, RR Kabel, KEI shares downgraded by JM Financial on rising competition; Stocks fall up to 8%
NewsCnbc-Tv18·2 Sept · today
Equirus on UltraTech's cables entry and whether it's time to buy the dip in Polycab, RR Kabel and KEI
NewsCnbc-Tv18·2 Sept · today
Polycab, KEI Industries, Havells shares fall up to 6% due to India's largest cement company; Here's why
NewsCnbc-Tv18·1 Sept · yesterday
Nothing found in this tip’s window yet.
1 advisor has an active swing BUY call on this stock, issued in the last 14 days
Advisor consensus · adjacent horizon·31 Aug · yesterday
BofA initiates coverage on Polycab, KEI with buy ratings; sees up to 22% upside
NewsEt-Markets·28 Aug · 5d ago
These two wires and cables stocks can gain up to 21% on BofA's bullish structural growth bets
NewsCnbc-Tv18·27 Aug · 6d ago
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Polycab India
- BUY — Jefferies India16 Oct 2026 · ~1 year · target ₹11,040 · Active
- BUY — BOB Capital Markets16 Oct 2026 · ~1 year · target ₹10,100 · Active
- BUY — Anand Rathi16 Oct 2026 · ~1 year · target ₹10,877 · Active
- BUY — Motilal Oswal16 Oct 2026 · ~1 year · target ₹10,600 · Active
- BUY — Nuvama Wealth16 Oct 2026 · ~1 year · target ₹10,000 · Active
More from Manas Jaiswal
- BUY Ajanta Pharma23 Oct 2026 · Same day · target ₹3,425 · SL hit
- BUY Torrent Pharmaceuticals23 Oct 2026 · Same day · target ₹4,725 · SL hit
- BUY SAGILITY23 Oct 2026 · ~2 weeks · target ₹50 · SL hit
- BUY Zydus Lifesciences22 Oct 2026 · ~3 months · target ₹1,160 · SL hit
- BUY IPCA Laboratories22 Oct 2026 · ~2 weeks · target ₹2,000 · Active

